1
Perry Ellis International Enters into a $437 Million Transaction to Become a Private Company Through an Acquisition Led by George Feldenkreis
2
Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
3
IMPORTANT SHAREHOLDER DEADLINE ALERT – ORMAT TECHNOLOGIES, INC.: Investors with Losses in Excess of $100,000 are Encouraged to Contact Kaskela Law LLC
4
ALLEGIANT TRAVEL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allegiant Travel Company - ALGT
5
NOTICE MYGN: Rosen Law Firm Reminds Myriad Genetics, Inc. Investors of Important Deadline in Class Action – MYGN
6
Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy Presented at the 2018 Annual Cure SMA Conference
7
RENAULT :Communication about availability - Renault sales figures for May 2018
8
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Class Actions Involving Myriad Genetics, Inc., Allegiant Travel Company, Aceto Corporation, and Gridsum Holding Inc.
9
Leadership Florida Honors the Jacksonville Area Sexual Minority Youth Network (JASMYN)
10
RENAULT : Groupe Renault launches the 2018 employee shareholding plan "Share the Future"